Eam Investors, LLC Castle Biosciences Inc Transaction History

Eam Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$58.92 - $97.33 $1.55 Million - $2.57 Million	-26,357 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$43.6 - $73.05 $1.67 Million - $2.8 Million	-38,278 Reduced 59.22%	26,357 $1.77 Million
Q3 2020 Nov 13, 2020	SELL	$38.47 - $52.03 $537,272 - $726,650	-13,966 Reduced 17.77%	64,635 $3.33 Million
Q2 2020 Aug 13, 2020	SELL	$27.28 - $43.01 $315,411 - $497,281	-11,562 Reduced 12.82%	78,601 $2.96 Million
Q1 2020 May 13, 2020	BUY	$23.08 - $35.53 $571,253 - $879,403	24,751 Added 37.84%	90,163 $2.69 Million
Q4 2019 Feb 11, 2020	BUY	$15.74 - $35.04 $494,346 - $1.1 Million	31,407 Added 92.36%	65,412 $2.25 Million
Q3 2019 Nov 13, 2019	BUY	$18.09 - $27.92 $615,150 - $949,419	34,005 New	34,005 $615,000

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $656M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.